As world population growing older, burden of age-related conditions soars. One of them is osteoarthritis (OA), a debilitating joint disease with no effective treatment. Articular cartilage degeneration is a central event in OA, and changes in expression of many genes in OA cartilage are well-documented. Still, the specific mechanisms are rarely known. We showed that in OA cartilage the increased abundance of many proteins, including extracellular matrix protein Fibronectin (Fn1) and an orphan nuclear receptor Nr4a1 is translationally controlled and requires inactivation of 4EBP, an inhibitor of cap-dependent translation. Importantly, intra-articular injection of the translation inhibitor 4E1RCat reduces Fn1 and Nr4a upregulation in a rodent OA model and delays cartilage degeneration. Our results support the hypothesis that maintaining proper translational control is an important homeostatic mechanism, the loss of which contributes to OA development.
INTRODUCTION
Extracellular matrix (ECM) determines many unique mechanical properties of articular cartilage. Fibronectin (Fn), an ECM protein, is a minor component of healthy cartilage; but in OA cartilage, there is an up to tenfold accumulation of the protein (1, 2) . Fn fragments induce proinflammatory cytokines, matrix-degrading metalloproteinases (MMPs), and suppress collagen and aggrecan expression leading to the loss of the biomechanical properties of cartilage (3) (4) (5) (6) . Both transcriptional (7) and post-transcriptional (2) regulation of Fn expression was proposed in different biological contexts, yet, the mechanism leading to an increase in Fn abundance in OA cartilage is not known. Different groups reported conflicting data on the Fn mRNA expression in OA cartilage. .
Few groups reported a modest increase in Fn RNA expression in OA cartilage compared to normal tissue (8, 9) , but the majority found no significant difference (10) (11) (12) (13) (14) . We, therefore, investigated if translational control is responsible for Fn1 abundance in OA cartilage.
The importance of translational control is emerging in understanding the vast majority of biological processes, particular as the assessment of mRNAs expression level often does not completely correlate with proteomic data. It is becoming apparent that in many cases the transcriptome does not accurately represent the proteome (15) . Recent publications began to address the role of post-transcriptional control of gene expression in chondrocyte homeostasis and OA progression (16) (17) (18) (19) . We used IL-1β stimulated primary articular chondrocytes as they possess many characteristics of OA chondrocytes. Importantly, IL-1β production is associated with cartilage degeneration in OA (20) , and it was shown that inflammatory molecules produced by synovium can induce ECM loss (21) . The importance of IL-1 signaling was also highlighted in animal models of posttraumatic OA (22) (23) (24) . Potential clinical relevance of identified translationally controlled targets, such as Fn1 and an orphan receptor Nr4a1, was tested in diseased cartilage and in a rat model of post-traumatic OA. To demonstrate the importance of translational control for cartilage homeostasis, we injected intra-articularly an inhibitor of cap-dependent translation. This treatment reduced Fn1 and Nr4a1 upregulation and significantly delayed OA progression. Our findings demonstrate that translational control, acting at Fn and Nr4a1 among other targets, is essential for maintaining cartilage homeostasis.
obtained by analyzing human Affymetrix U133A microarray data (Sup.1B). These data indicate that increased FN1 protein abundance is controlled post-transcriptionally in human OA cartilage. We observed similar results in a rat anterior cruciate ligament transection (ACLT) model of post-traumatic OA. Animals were sacrificed 20 weeks post-op. Mankin scoring system of Toluidine Blue stained tissue was used to assess the severity of cartilage lesions (with numbers ≥ 10 indicating the onset of OA) (30) (Sup.1C). Fn1 mRNA level was not changed in operated compared to sham joints, but IHC analysis confirmed increased Fn1 (and Mmp13) protein level in OA cartilage (Fig.1B, Sup.1D, 1E ).
As an inflammation component is well described in OA pathology, we used IL-1β treated primary rat articular chondrocytes (RAC) as an "in vitro" model that displays many characteristics of OA chondrocytes, including secretion of Mmps (31). For polysome analysis untreated and IL-1β treated RAC lysates were fractionated on a sucrose gradient. Actively translated mRNAs are present in the polysome (heavy) fractions, while translationally repressed mRNAs are excluded (Sup.2A). Actively translated (bound to polysomes) mRNAs (mRNA poly ) were isolated from polysome fractions, and Fn1 and Mmp13 mRNA levels were examined. IL-1β signaling considerably increases mRNA poly levels for both Mmp13 and Fn1 (Fig.1C ), but only total Mmp13, not Fn1 mRNA level is significantly increased, indicating that Fn1 protein abundance is likely mediated by translation control (Fig.1C ). This raises an important question; are there other translationally regulated proteins in OA-like chondrocytes? Their (not all) mRNAs would primarily benefit from accelerated protein synthesis in OA cartilage (18) . To answer this question, we next characterize the translatome of IL-1β treated RAC using deep sequencing of polysome-associated mRNAs (mRNA poly ).
Polysome profiling in articular chondrocytes identifies dynamic regulation of the translatome by IL-1β.
Primary RAC were treated for 24hrs with IL-1β, and polysomal fractions were sequenced in parallel with total mRNA (Sup.2A). First, we compared polysome profiles of IL-1β treated and untreated RAC ( Fig.1D , Sup.2B). Fold changes (FC) of mRNA poly ≥ 1.5 were significantly different for 369 genes (Sup.Table1). These changes can be mediated by changes in mRNA abundance, or/and by translational regulation. We therefore evaluated transcriptional changes in IL-1β treated RAC (Sup. 2C). Out of 12721 genes, 776 genes were differentially expressed (FC≥1.5) (Sup.Table2). RNAseq data were validated further with qPCR (R=0.84; Sup. 2D). For majority of identified genes mRNAs abundance determined their expression. Thus, IL-1β induced increase in total Mmp13 mRNA and mRNA poly levels is similar (7.95 vs. 7.48), meaning that Mmp13 expression is regulated predominantly at the transcriptional level. Likewise, transcription determines monoglyceride Lipase (Mgll) expression, as both Mgll mRNA total and mRNA poly were decreased ( Fig.2A ).
To identify translationally regulated genes, we merged two datasets (mRNA poly (369 genes) and total mRNA (776)) generating a set of 848 genes. 617 genes with the ratio between FC(Total mRNA(IL-1β/control )) to FC(mRNA poly (IL-1β/control) ≥ 1.3 and ≤ 0.77 (an arbitrary cutoff implying that there is a substantial translational component in the regulation of gene expression) were taken for further consideration. For example, for Fn1 and Sulfatase 1 (Sulf1), FCs between transcriptome and translatome were significantly different (0.54 vs 2.33) and (2.71 vs. 1.88) respectively ( Fig.2B ). 100 out of 617 entries that had RNAseq data for both total mRNA and mRNA poly (in bold in Sup. Table4) were analyzed further. Top translationally upregulated by IL-1β signaling mRNAs include Anthrax Toxin Receptor2, Fn1, and Cathelicidin Antimicrobial Peptide (Sup. and Acan were found on polysomes. The top 10 translationally repressed mRNAs include those encoding Fn1 (about 1% is being translated), thrombospondin and proteins involved in cytoskeleton formation. Among efficiently translated mRNAs in unchallenged chondrocytes we detected cartilagespecific protein CD-RAP/MIA, Phospholipase A2 Group IIA, and S100 Calcium Binding Protein A6 (35).
Thus, polysome profiling identified a substantial set of genes whose protein abundance is translationally regulated by IL-1β signaling.
Expression of translationally activated targets in rodent and human OA cartilage.
We next tested if identified targets are translationally regulated in vivo. Immunostaining (IHC) of Sulf1, Plau and Nr4a1 was significantly increased in operated compared to sham joints. The similar result was obtained when cells isolated from animals were analyzed by WB or IF (Fig.3A , 3D, Sup.3B). Importantly, no significant changes were observed in Nr4a1 and Fn mRNA levels isolated from either sham or ACLT joints (Sup.1E). We next analyzed lesional and non-lesional areas of human OA cartilage isolated from the same patient (n=4). We observed increased immunostaining in lesion areas for Sulf1, Nr4a1, Mmp13, and Plau ( Fig.3B ; Sup.3C) (36). No significant changes were detected in Nr4a1 mRNA level when OA (n=12) and non-OA (n=9) cartilage was analyzed by qPCR or by Affymetrix U133A microarray ( Fig.3C ; Sup.3D, 3E). Sulf1 mRNA expression were slightly upregulated in OA compared to normal cartilage (similar to our polysome profiling data) indicating that synergy between transcriptional and translational regulation drives its expression. We next treated cells isolated from non-lesion areas with IL-1β to confirm that translational upregulation is mediated by IL-1β signaling. Nr4a1 and Fn1 protein levels were increased (Fig.3E ). The level of upregulation fluctuated from a patient to a patient, reflecting the heterogeneous nature of the diseases.
Importantly, there were no significant changes in Fn1 and Nr4a1 mRNA levels (Sup.3F). Our data indicate that increased protein abundance of Fn1 and Nr4a1 is primarily controlled at the translational level in OA cartilage and likely mediated by pro-inflammatory signaling.
5' Untranslated Regions (UTRs) are responsible for IL-1β mediated translational
upregulation. We demonstrated that 4E-BP, an inhibitor of cap-dependent translation is inactivated in OA cartilage (18). 4E-BP acts as a repressor by sequestering eukaryotic initiation factor 4E (eIF4E) cap-binding protein, which is a part of eIF4F complexes. eIF4F is crucial for binding of the ribosomal complexes onto the 5'cap structure of mRNAs and unwinding RNA structures that precede to the initiation codon. It is well established that different mRNAs have different requirements for eIF4F depending on the length and structure of their 5'UTRs. mTORC1-mediated phosphorylation of Thr37/46/70 and Ser65 restricts 4E-BP ability to bind eIF4E . We next determined if 4E-BP inactivation (which would ultimately increase the amount of active eIF4F) is crucial for upregulation of genes of our interest at the protein level. We used 4E-BP(AA) dominant-negative mutant which has Thr37/46 to Ala substitutions and therefore cannot be inactivated by phosphorylation (37). 4E-BP(AA) overexpression strongly reduced mRNA poly and protein upregulation of examined targets when compared to RAC expressing a parental vector supporting our hypothesis that their 5'UTRs might play an important role in regulation of translation ( Fig.4A ;Sup.4A,4B). We next examined if Fn1, Sulf1, and Nr4a1 5'UTRs are functionally important using a luciferase reporter . 5'UTRs were cloned into pIS0 vector upstream a luciferase cDNA, and their activity upon IL-1β stimulation was assayed. Mmp13 5'UTR was used as a negative control. An increase in Luc expression was detected for all but Mmp13 5'UTR ( Fig.4B ). While Fn1 and Sulf1 effect was anticipated, as their 5'UTRs are quite long (215 and 415nts), the strong effect of Nr4a1 5'UTR (120nt) was rather surprising. This sequence can potentially form a highly structured fold that includes pseudoknots ( Fig.4C) , thus increasing the demand in eIF4F. We disrupted this structure by deleting 27nts in the loop structure. The Nr4a1 5'UTR mutant failed to upregulate Luc expression upon IL-1β stimulation, indicating the importance of this element/structure for efficient Nr4a1 translation ( Fig.4C ).
This result supports our hypothesis that 5'UTRs of Fn1, Sulf1, and Nr4a1 are important determinants of their effective translation and are sensitive to 4E-BP activity upon IL-1β signaling in vitro and likely in vivo. Other pro-inflammatory cytokines stimulating mTORC1 activity would ultimately lead to 4E-BP inactivation as well and have the similar effect on translationally regulated genes.
IL-1β mediated increase in ECM metalloproteinases requires Nr4a1.
. To corroborate the importance of newly identified Nr4a1 for OA pathology, we investigated if its functions are important for mediating pro-inflammatory response in chondrocytes. Nr4a1 is an orphan nuclear transcription factor that is involved in multiple processes in metabolism, and inflammation (38). It was reported that Nr4a1 mRNA level is similar in OA and normal cartilage, and another member of this receptor family-Nr4a2 was implicated in synoviocyte invasion and Mmp13 expression (39). We inhibited Nr4a1 This robust response is likely due to suppression of IL-6 expression in IL-1β treated cells in the presence of DIM ( Fig.4E ), as Nr4a1 is IL-6 upstream regulator (41). IL-6, in turn, is linked to OA progression (42). Thus, Nr4a1 is important for mediating IL-6 expression and a pro-inflammatory response of chondrocytes. More experiments are needed in order to understand the mechanism of Nr4a1 functions in cartilage homeostasis starting with the characterization of the chondrocyte-specific repertoire of Nr4a1 targets.
Inhibition of cap-binding transaltion delays OA progression in the ACLT model.
mTORC1 is a master regulator of 4E-BP activity. mTORC1 inhibition attenuates the effect of IL-1β signaling on protein synthesis and MMPs expression in articular chondrocytes (18).
Intraperitoneal administration of Rapamycin, a mTORC1 inhibitor (43), significantly reduced the severity of cartilage degradation in a mouse model of post-traumatic OA (44).The similar protective effect was observed with the cartilage-specific ablation of mTOR (45). In both cases, autophagy was assessed as a downstream target of mTOR, though 4E-BP should be affected as well. We specifically inhibited mTORC1/4E-BP/eIF4E axis in order to examine its role in OA progression. We used 4E1RCat inhibitor that blocks cap-dependent translation by inhibiting eIF4E (46). In vitro, 4E1RCat
prevented IL-1β induced upregulation of protein synthesis and Mmps in RAC ( Fig.5A ,5B,Sup.6A,6B).
4E1RCat (or a vehicle) was injected into ACLT or sham-operated joints (n=7 for each group) 8 weeks post-op weekly for 4 weeks (Sup. 6C). This timing was based on our data that upregulation of total protein synthesis is detected at 12 weeks post-op in our OA model 4E1RCat treatment significantly reduced cartilage degeneration in operating joints ( Fig.5C ). Consistent with these data, the level of active Mmp13 was also significantly reduced in cells isolated from ACLT joints treated with 4E1RCat ( Fig.5D ). Sulf1, Nr4a1, and Fn1 protein abundance was decreased in the 4E1RCat treated joints as analyzed by WB and IHC ( Fig.5E ,Sup.6D). Thus, intra-articular administration of the eIF4E inhibitor reduced cartilage degeneration in OA joints and attenuated the effect of injury on the expression of translationally controlled genes.
DISCUSSION
The presented results provide evidence for an important role of translational control in cartilage homeostasis. As our polysome profiling data are unique, we can only compare them with existing transcriptome data of pro-inflammatory response in cartilage. The observed similarities include increased expression of numerous inflammatory mediators (IL-6, IL23r, and CXCL1), and growth factors (BMP-2 and BMP-6) (47, 48). Aggrecan-1 downregulation and increase in several MMPs expression were also detected.
Polysome profiling revealed that many components of ECM including fibronectin are translationally repressed in unchallenged chondrocytes despite relatively high mRNA levels. This repression is consistent with the low mitotic activity of the residing chondrocytes (49, 50). However, high mRNA abundance of Fn1 in unchallenged chondrocytes makes this gene a quick responder to different stimulus through protein abundance in OA cartilage. Interestingly, while human FN1 gene has three alternatively spliced regions, with the potential to produce 20 different transcript variants, most of these variants have the same 5'UTR which as we demonstrated is important for Fn1 efficient translation. Our data are in line with an early work that suggested the regulation of Fn1 expression in OA cartilage through protein synthesis (2) as well as with data demonstrated an increase in Fn1 protein (but not mRNA) level in OA cartilage (10, 11, 13) . It is important to notice that while we used IL-1β, other pro-inflammatory cytokines stimulating mTORC1 activity would ultimately lead to 4E-BP inactivation and have similar effect on translationally regulated genes and on protein synthesis in general. Further work is needed to understand the specific contribution of diverse signaling pathways involved in OA pathology (51). We demonstrated that in post-traumatic animal OA model 4E-BP inactivation in articular cartilage is one of the earliest events following traumatic insult onto the joint that precedes Mmp13 and Mmp3 upregulation and degeneration of articular cartilage (52). Immediate 4E-BP inactivation in the post-traumatic joint is likely advantageous for a specific pool of mRNAs those translational efficiencies strongly depend on eIF4F activity, such as identified here Fn1 and Nr4a1. The dependence of translational landscape on 4E-BP/eIF4F activity likely changes as disease advances, adjusting to epigenetic and metabolic changes resulted from mechanical stress and low grade inflammation processes.
Polysome analysis of IL-1β treated articular chondrocytes revealed novel potential players in OA pathology, such as an orphan nuclear receptor Nr4a1 those abundance is elevated in human and rodent OA cartilage at protein but not mRNA level. Mix et al. also reported that Nr4a1 mRNA levels are similar in OA and normal cartilage (53). Our experiments with DIM inhibitor demonstrated that Nr4a1 is crucial for mediating IL-6 expression and a pro-inflammatory response of chondrocytes in general. More experiments are needed in order to understand the mechanism of Nr4a1 functions in cartilage homeostasis starting with the characterization of the chondrocyte-specific repertoire of Nr4a1 targets. Our in vitro and in vivo data provided a rationale for targeting translational apparatus to limit/delay the progression of cartilage degeneration in OA. In support of our premises, genetic or pharmacological inhibition of mTORC1 delayed cartilage degeneration in a mouse model of posttraumatic OA (44, 45) . To target protein synthesis specifically, we used 4E1RCat, a chemical inhibitor of eIF4E. Intra-articular administration of 4E1RCat reduced cartilage degeneration and attenuated the effect of ACLT on the expression of translationally controlled genes: Fn1, Sulf1, and Nr4a1, but not actin. With further optimization of regime and delivery approach, 4E1RCat (or similar compounds) might be considered for clinical applications.
Another important aspect of post-transcriptional control -RNA/protein turnover should also be assessed in future studies. Thus, it was demonstrated that the stability of Plau mRNA is increased in OA tissue, making mRNA turnover an additional important factor that regulates Plau expression (16) . We demonstrated that Plau protein abundance is also translationally upregulated upon proinflammatory signaling. Thus, this example shows how multiple levels of regulation converge to adapt to tissue specific changes.
In summary, using polysome profiling, we identified novel OA-related targets, thus underlying the exceptional potential of our approach for discovering new players in human OA cartilage. These functionally unrelated targets might be regulated as a selective pool by fine-tuning their translation efficiency through careful incremental modulation of eIF4F activity, while keeping translation of most of the genes unchanged.
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